EU chemical agency gives first hazardous substance authorisation


The European Chemicals Agency (ECHA) has granted its first approval to use a substance of very high concern (SVHC). Rolls Royce applied to use the chemical bis(2-ethylhexyl) phthalate (DEHP), which can cause central nervous system damage and birth defects, for the bonding of fan blades in jet engines.

SVHCs have been defined by the ECHA as those that cause irreversible damage to human health or the environment. If a chemical is put on this list it is the first step towards having its use restricted under the EU’s registration, evaluation, authorisation and restriction of chemicals (Reach) regulations.

The ECHA came to the conclusion that Rolls Royce’s plans to control exposure to DEHP were adequate. The final decision by the European commission will be based on the ECHA’s recommendations, which will be revisited in seven years time.


Related Content

Dangerous delivery problems dog chemical transport in China

26 February 2014 News and Analysis

news image

Lethal accident caused by contamination of parcels by toxic chemical highlights difficulties faced by small firms

Flexible lighting is on a roll

14 August 2012 Research

news image

Light emitting sheets thinner than a piece of paper have been made in a similar manner to printing a newspaper

Most Read

Quintuple bond activates small stable molecules

19 September 2014 Research

news image

Exotic complexes suggest route to synthetic feedstock

Computer simulations point to formamide as prebiotic intermediate in ‘Miller’ mixtures

16 September 2014 News and Analysis

news image

Electric field may have provided more than just energy for primordial chemistry

Most Commented

Painkiller found in plants may not be natural after all

18 September 2014 Research

news image

Cow pats from cattle fed tramadol could explain how the drug came to be in an African herb

US genomics lead being lost to China

17 September 2014 News and Analysis

news image

NIH senior leaders are sounding the alarm bells, saying the US's pre-eminence in genomics research is under threat